|
|
||||||||
1 From the Laboratory of Retinal Cell Biology, University Hospital Zurich, Zürich, Switzerland; the 2 Retinal Electrodiagnostics Research Group, Department of Ophthalmology, University of Tübingen, Germany; and the 3 Central Laboratory of Chemistry, Inselspital Bern, Switzerland.
PURPOSE. Evidence has accumulated that excessive light exposure may promote age-related and inherited retinal degeneration, in which photoreceptor death by apoptosis leads to loss of vision. In the current study, the effect of elevated corticosteroid levels on light-induced apoptosis of photoreceptors was determined.
METHODS. Photoreceptor apoptosis was induced in retinas of BALB/c mice by exposure to diffuse white light. High levels of corticosteroids were induced, either endogenously (fasting-mediated stress) or by a single intraperitoneal injection of dexamethasone (DEX). Photoreceptor damage was assessed morphologically and by electroretinography. Glucocorticoid receptor (GR) and activator protein (AP)-1 activities were shown by Western blot analysis and electrophoretic mobility shift assay (EMSA) of retinal nuclear extracts.
RESULTS. Fasting and injection of DEX led to an activation of GR in the retina, as judged by its translocation to the nucleus of retinal cells. On induction of GR activity before light exposure, AP-1 activity, normally induced by damaging doses of light, remained at basal levels. Both treatments completely prevented photoreceptor apoptosis and preserved retinal function.
CONCLUSIONS. Activity of the transcription factor AP-1 is associated with light-induced apoptosis. In the current study, pharmacologic suppression of AP-1 activity protected against light damage. Inhibition of AP-1 activity may have occurred by the proteinprotein interaction of GR and AP-1.
This article has been cited by other articles:
![]() |
X. Zhang, S. Bao, D. Lai, R. W. Rapkins, and M. C. Gillies Intravitreal Triamcinolone Acetonide Inhibits Breakdown of the Blood-Retinal Barrier Through Differential Regulation of VEGF-A and Its Receptors in Early Diabetic Rat Retinas Diabetes, April 1, 2008; 57(4): 1026 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gu, W. A. Beltran, Z. Li, G. M. Acland, and G. D. Aguirre Clinical Light Exposure, Photoreceptor Degeneration, and AP-1 Activation: A Cell Death or Cell Survival Signal in the Rhodopsin Mutant Retina? Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 4907 - 4918. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. White, W. W. Hauswirth, S. Kaushal, and A. S. Lewin Increased Sensitivity to Light-Induced Damage in a Mouse Model of Autosomal Dominant Retinal Disease Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 1942 - 1951. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Harms, K. Albrecht, U. Harms, K. Seidel, L. Hauck, T. Baldinger, D. Hubner, G. Kronenberg, J. An, K. Ruscher, et al. Phosphatidylinositol 3-Akt-Kinase-Dependent Phosphorylation of p21Waf1/Cip1 as a Novel Mechanism of Neuroprotection by Glucocorticoids J. Neurosci., April 25, 2007; 27(17): 4562 - 4571. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Samardzija, A. Wenzel, S. Aufenberg, M. Thiersch, C. Reme, and C. Grimm Differential role of Jak-STAT signaling in retinal degenerations FASEB J, November 1, 2006; 20(13): 2411 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dierks, B. Lei, K. Zhang, and D. P. Hainsworth Effects of Intravitreous Injection of Preserved and Nonpreserved Triamcinolone in Rabbit Retina--Reply Arch Ophthalmol, November 1, 2006; 124(11): 1666 - 1668. [Full Text] [PDF] |
||||
![]() |
D. Dierks, B. Lei, K. Zhang, and D. P. Hainsworth Electroretinographic Effects of an Intravitreal Injection of Triamcinolone in Rabbit Retina Arch Ophthalmol, November 1, 2005; 123(11): 1563 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Reme The Dark Side of Light: Rhodopsin and the Silent Death of Vision The Proctor Lecture Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2672 - 2682. [Full Text] [PDF] |
||||
![]() |
H. Tomita, Y. Kotake, and R. E. Anderson Mechanism of Protection from Light-Induced Retinal Degeneration by the Synthetic Antioxidant Phenyl-N-tert-Butylnitrone Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 427 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huang, F. Li, R. A. Alvarez, J. D. Ash, and R. E. Anderson Downregulation of ATP Synthase Subunit-6, Cytochrome c Oxidase-III, and NADH Dehydrogenase-3 by Bright Cyclic Light in the Rat Retina Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2489 - 2496. [Abstract] [Full Text] [PDF] |
||||
![]() |
P GUARNERI, C CASCIO, D RUSSO, S D'AGOSTINO, G DRAGO, G GALIZZI, G DE LEO, F PICCOLI, M GUARNERI, and R GUARNERI Neurosteroids in the Retina: Neurodegenerative and Neuroprotective Agents in Retinal Degeneration Ann. N.Y. Acad. Sci., December 1, 2003; 1007(1): 117 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ranchon, M. M. LaVail, Y. Kotake, and R. E. Anderson Free Radical Trap Phenyl-N-tert-Butylnitrone Protects against Light Damage But Does Not Rescue P23H and S334ter Rhodopsin Transgenic Rats from Inherited Retinal Degeneration J. Neurosci., July 9, 2003; 23(14): 6050 - 6057. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Herr, E. Ucur, K. Herzer, S. Okouoyo, R. Ridder, P. H. Krammer, M. von Knebel Doeberitz, and K.-M. Debatin Glucocorticoid Cotreatment Induces Apoptosis Resistance toward Cancer Therapy in Carcinomas Cancer Res., June 15, 2003; 63(12): 3112 - 3120. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wenzel, C. Grimm, M. Samardzija, and C. E. Reme The Genetic Modifier Rpe65Leu450: Effect on Light Damage Susceptibility in c-Fos-Deficient Mice Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2798 - 2802. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Zacks, V. Hanninen, M. Pantcheva, E. Ezra, C. Grosskreutz, and J. W. Miller Caspase Activation in an Experimental Model of Retinal Detachment Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1262 - 1267. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |